Evigrade

Poloxamer 182

A mild non-ionic surfactant and solubilizer. It dissolves oils and actives and helps gentle cleansing. Well tolerated.

Supporting ingredient

It gives a product its texture, stability or shelf life. It has no claimed effect on the skin, so an efficacy tier does not apply. What is known about its safety is below

Tolerability and safety

Irritation potential
Low
Allergen risk
Low
Pregnancy
Safe
Suitable for
Normal, Dry, Combination, Oily, Sensitive

About this ingredient

Poloxamer 182 (INCI: Poloxamer 182) is a mild nonionic surfactant that also works as a solubilizer. It dissolves oils and poorly soluble actives and helps with gentle cleansing in gels and solutions. This is a functional ingredient, not a skincare active. Its job is to cleanse and dissolve, not to improve skin on its own. No skincare result should be expected from it. Because of its topical use and lack of systemic relevance, it can be used during pregnancy and breastfeeding without concern. Tolerance is high. It is one of the milder surfactants, with low irritation and allergy potential, so it treats sensitive skin more kindly than many classic detergents. Most skin does not react.

Frequently asked questions

Is Poloxamer 182 safe during pregnancy?

Poloxamer 182 is considered safe during pregnancy at typical cosmetic concentrations. Systemic absorption through the skin is minimal.

What skin types is Poloxamer 182 for?

Poloxamer 182 suits: normal, dry, combination, oily, sensitive.

What is Poloxamer 182 and what does it do in cosmetics?

A mild non-ionic surfactant and solubilizer.

What's the INCI name for Poloxamer 182?

The INCI name is Poloxamer 182.

See Poloxamer 182 in a product composition right on the store page

The Evigrade extension adds an evidence panel to iHerb, Sephora, Druni and 12 more stores. This ingredient and every other one in the product show evidence-tier, allergen risk and pregnancy/lactation flags at a glance.

Install the extension for free

Similar role in the formula

Published: · updated: